Riskpilot← Back to searchSign inGet full accessAfrident AB
ABActiveOrg 5593078040TäbyWholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2024
SEK 205K
-24% vs 2023
EBITDA margin
-22.4%
+21% vs 2023
Equity ratio
475.0%
Financial strength
Net profit 2024
SEK -45K
+22% vs 2023
| Revenue | SEK 205K | -24% |
| EBITDA | SEK -46K | +21% |
| Net profit | SEK -45K | +22% |
| Total assets | SEK 12K | -91% |
| Equity | SEK 57K | +10% |
| Employees | 0 | — |
Legal name
Afrident AB
Org number
5593078040
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18 mars 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Hellman, Jörgen Erik
Company purpose
Importering and försäljning av tandvårds utrustning, agera som agent inom försäljning av tandvårds utrustning samt erbjuder konsultering i detta område. Bolaget ska även bygga tandvårdskliniker samt erbjuda träning inom tandvårdsservice tekniker.
Address
Täby
Email
jh@jh.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | — | 354 | 271 | 205 |
| Staff expenses | — | — | — | — |
| EBITDA | 0 | 4 | −58 | −46 |
| Depreciation & amort. | — | −0 | −0 | −0 |
| EBIT | 0 | 4 | −58 | −46 |
| Net financials | — | −2 | — | 1 |
| Profit before tax | 0 | 2 | −58 | −45 |
| Tax | — | −0 | −0 | −0 |
| Net profit | — | 2 | −58 | −45 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | — | 134 | 138 | 12 |
| Equity | — | 109 | 52 | 57 |
| Long-term debt | — | 30 | 79 | 0 |
| Short-term debt | — | 5 | 7 | 45 |
| Total debt | — | 35 | 86 | 45 |
EBITDA margin
-22.4%
This company
15.8%
Market median
-242% vs market
20212024
Equity ratio
475.0%
This company
38.2%
Market median
+1143% vs market
20212024
Return on equity
-78.9%
This company
18.4%
Market median
-529% vs market
20212024
Net profit margin
-22.0%
This company
8.1%
Market median
-372% vs market
20212024
Asset turnover
17.08×
This company
1.12×
Market median
+1425% vs market
20212024
Debt / equity
-0.79×
This company
0.62×
Market median
+227% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Afrident AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Baboucar Amar | Board of Directors | 0 companies |
| Jörgen Erik Hellman | Board of Directors | 0 companies |
| Mohammad Mohiul Haque Millat | Deputy Board Member | 0 companies |
| Nenneh Janneh Amar | Deputy Board Member | 0 companies |